Skip to main content

DICE Therapeutics, Inc.

DICEDelisted Aug 9, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001645569

DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding DICE Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of DICE: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders039+39
Shares024.4M+24.4M
Value$0$793.6M+$793.6M

New holders (39)

Institutions that held DICE Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to DICE in Q3 2021
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.5,208,911$170.6M2.36%
Sands Capital Ventures, LLC3,148,970$103.1M15.55%
Driehaus Capital Management LLC2,053,400$67.2M0.80%
Eventide Asset Management, LLC1,871,612$59.2M0.78%
Janus Henderson Group PLC1,864,207$58.6M0.03%
Price T Rowe Associates Inc1,502,249$49.2M0.00%
Logos Global Management LP1,160,251$38.0M2.74%
FMR LLC964,500$31.6M0.00%
Soleus Capital Management, L.P.879,903$28.8M4.49%
Avoro Capital Advisors LLC800,000$26.2M0.41%
Baker Bros. Advisors LP588,235$19.3M0.08%
New Leaf Venture Partners, L.L.C.556,693$18.2M5.26%
OrbiMed Advisors LLC440,000$14.4M0.16%
ArrowMark Colorado Holdings LLC410,433$13.4M0.11%
Suvretta Capital Management, LLC410,000$13.4M0.23%
Vivo Capital, LLC410,000$13.4M0.60%
Millennium Management LLC366,556$12.0M0.02%
Asymmetry Capital Management, L.P.275,165$9.01M5.42%
Woodline Partners LP250,058$8.19M0.14%
Adage Capital Partners GP, L.L.C.250,000$8.19M0.02%
Board of Trustees of The Leland Stanford Junior University233,914$7.66M0.57%
Miller Investment Management, LP180,901$5.92M1.02%
Sphera Funds Management Ltd.85,000$2.78M0.28%
Tudor Investment Corp Et Al83,970$2.75M0.06%
LMR Partners LLP60,000$1.97M0.03%
Marshall Wace North America L.P.43,062$1.41M0.01%
HealthCor Management, L.P.42,800$1.40M0.06%
Marshall Wace, LLP42,500$1.39M0.01%
TD Asset Management Inc40,826$1.34M0.00%
Ergoteles LLC40,800$1.34M0.05%
Goldman Sachs Group Inc39,000$1.28M0.00%
Atika Capital Management LLC28,389$930.0K0.07%
Maven Securities LTD8,065$264.0K0.03%
M&T Bank Corp7,828$256.0K0.00%
Samson Rock Capital LLP7,333$240.0K0.15%
Qube Research & Technologies Ltd6,788$222.0K0.00%
Point72 Hong Kong Ltd6,205$203.0K0.02%
Citigroup Inc1,306$43.0K0.00%
Bank of America Corp1,178$38.0K0.00%

Sold out (0)

Institutions that held DICE Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

None.